Compugen (CGEN) Operating Income (2009 - 2026)
Compugen (CGEN) reported Operating Income of $9.0 million for Q1 2026, up 7.41% on a YoY basis from $8.4 million in Q1 2025, and down 83.91% sequentially from $56.0 million in Q4 2025.
Compugen (CGEN) Operating Income (2009 - 2026) Analysis & Trends
Compugen (CGEN) has 18 years of Operating Income data on file, last reported at $9.0 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Income rose 7.41% year-over-year to $9.0 million; the trailing twelve-month figure through Mar 2026 stood at $31.9 million (up 313.16% YoY), and the FY2025 full-year result was $31.3 million, up 310.37% from the prior year.
- Operating Income fell to $9.0 million in Q1 2026, from $56.0 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of $56.0 million in Q4 2025 to a low of -$30.5 million in Q2 2023.
- A 5-year average of -$218733.3 and a median of -$3.5 million in 2022 frame the typical range for Operating Income.
- Peak annual rise in Operating Income reached 848.94% in 2025, while the deepest fall reached 275.56% in 2025.
- Tracing CGEN's Operating Income over 5 years: stood at -$3.5 million in 2022, then surged by 609.61% to $18.0 million in 2023, then slumped by 141.61% to -$7.5 million in 2024, then surged by 848.94% to $56.0 million in 2025, then sank by 83.91% to $9.0 million in 2026.
- Business Quant data shows CGEN's Operating Income at $9.0 million in Q1 2026, $56.0 million in Q4 2025, and -$7.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Compugen | 221.26 Mn | 129.51 Mn | 352,000.00 | 9.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.02 Mn |
| Dec 31, 2025 | 56.04 Mn |
| Sep 30, 2025 | -7.89 Mn |
| Jun 30, 2025 | -25.22 Mn |
| Mar 31, 2025 | 8.40 Mn |
| Dec 31, 2024 | -7.48 Mn |
| Sep 30, 2024 | 4.50 Mn |
| Jun 30, 2024 | -20.40 Mn |
| Mar 31, 2024 | 8.49 Mn |
| Dec 31, 2023 | 17.98 Mn |
| Sep 30, 2023 | -10.63 Mn |
| Jun 30, 2023 | -30.48 Mn |
| Mar 31, 2023 | 10.13 Mn |
| Dec 31, 2022 | -3.53 Mn |
| Sep 30, 2022 | -12.21 Mn |
| Dec 31, 2021 | -8.78 Mn |
| Sep 30, 2021 | -6.33 Mn |
| Mar 31, 2021 | -10.26 Mn |
| Dec 31, 2020 | -9.09 Mn |
| Mar 31, 2020 | -7.40 Mn |